Search / Trial NCT06236282

ArtiSential® for Rectal Cancer Surgery

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jan 23, 2024

Trial Information

Current as of October 08, 2024

Completed

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * mid-to-low rectal caner (witing 10cm of the anal verge)
  • * laparoscopic surgery
  • Exclusion Criteria:
  • * combined surgery
  • * recurrent rectal cancer surgery

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seoul, , Korea, Republic Of

Seoul, Jongno Gu, Korea, Republic Of

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0